Regulatory clarity fromthoughttofinish
Webinar: FDA Fallout & the Future
In a climate of regulatory transformation, uncertainty at the FDA is reshaping the life sciences landscape. Shifting FDA priorities, reduced agency resources, and structural realignments introduce growing ambiguity around approval timelines, enforcement priorities, and post-market expectations.
Join ELIQUENT for a live webinar exploring how life sciences organizations can remain agile, proactive, and inspection-ready amid regulatory uncertainty. With decades of collective experience across regulatory, quality, and safety functions, our team of regulatory leaders and industry experts will share their unique insights and pragmatic solutions to adapt and plan for what’s ahead.
Whether you’re preparing for upcoming submissions, navigating post-market changes, or building resilience into your regulatory operations—this session is designed to help you respond with confidence.
Webinar Details
Date: Wednesday, June 11, 2025
Time: 11am – 12pm ET
Location: Virtual
What to Expect
Insights on current regulatory trends and potential disruptions
Practical strategies for managing amid uncertainty
Real-world examples of how companies are adapting to accelerated change
Q&A with ELIQUENT experts across regulatory, quality, and safety disciplines
Register
Follow this link to register for the webinar
Meet the Panel
With years of experience at the FDA and within regulated industry, our panel of ELIQUENT Experts bring a unique, insider perspective to the complex transitions shaping the agency. Having worked on regulatory policy, enforcement, and industry compliance, they’ve seen firsthand how leadership and regulatory shifts impact FDA priorities, approvals, and oversight.
Their deep institutional knowledge, combined with real-world industry insights, allows them to break down these changes in a way that’s both informative and actionable for stakeholders navigating this evolving landscape
John Taylor, JD
More than 30 years of global leadership in the life sciences industry including roles as a senior FDA official acting in multiple high-profile positions at the Agency and leadership roles within industry.
Learn more about John
Kalah Auchincloss, JD, MPH
More than 15 years of life science experience with senior roles across Capitol Hill, in the private sector, and at the FDA, including service as FDA’s Deputy Chief of Staff.
Learn more about Kalah
Brian Mayhew, MA, MBA
More than 25 years of regulatory policy experience in the life sciences industry, including roles in the FDA’s Office of the Commissioner and senior positions throughout industry.
Learn more about Brian
Wendy Sanhai, PhD, MBA
Distinguished life sciences leader, scientific expert, and member of ELIQUENT’s Board of Directors with experience that spans senior roles at FDA and NIH, academia, and regulated industry.
Learn more about Wendy
Regulatory Roadmap Podcast
Interested in learning more about the profound changes occurring within the U.S. Food and Drug Administration (FDA) and the broader regulatory landscape during President Donald Trump’s second term? Join us as we engage with former FDA senior officials, policy experts, and industry leaders to provide firsthand insights into how these transitions are reshaping the FDA and the industries it regulates.
Stay tuned for our upcoming episodes, where we bring you in-depth analyses and conversations on the critical issues at the intersection of politics, regulation, and public health.
LISTEN: Week of May 10, 2025
Kalah and Brian offer timely insights and practical advice to help companies stay compliant and confident—even as the rules evolve. In this episode, our hosts address the status of the FDA reorganization, implications of recent Supreme Court decisions on federal regulatory authority, and what a push toward deregulation could mean for FDA guidance and enforcement.
LISTEN: Week of April 14, 2025
In this timely episode, Kalah and Brian unpack the recent workforce reductions at the FDA. Drawing on their direct experience navigating FDA interactions, our experts provide clarity on the evolving regulatory landscape and offer strategic guidance for companies facing increased uncertainty.
LISTEN: Week of February 17, 2025
Kalah and Brian kick-off the first podcast with a discussion of recent workforce reductions, Presidential Executive Orders, and the potential impact on public health. Listen as our experts address the challenges, implications, and strategies for navigating this evolving landscape.
Ready for Regulatory Clarity?
Stay informed as the regulatory landscape evolves – subscribe to receive the latest updates on policy changes, FDA developments, and their impact on the life sciences industry.